We independently confirmed this finding at the protein level (Figure S3B), and further found that additional potent inducers of immune signaling, such as poly(I:C) treatment and direct infection with SARS-CoV-2, did not lead to significant upregulation of full-length ACE2 at the protein level. Here, ACE2 is linked to infection.